Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s revision indicator in the footer was updated from v3.6.5 to v3.6.6, signaling a small maintenance update to the page version. No user-facing content changes are introduced.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now reflects a software revision bump from v3.6.4 to v3.6.5, indicating an update to the underlying platform. This change represents a backend/version upgrade rather than a modification to study information shown on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe history entry now shows Revision: v3.6.4 in place of v3.6.3. This updates the revision tag displayed for the study record on the history page.SummaryDifference0.0%

- Check69 days agoChange DetectedA new page revision (v3.6.3) is added to the history, replacing the previous revision (v3.6.2). This indicates a software/record update applied to the page.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision entry v3.6.2 was added to the page history, and the older v3.6.0 entry was removed. This represents a software update to the site without altering study content or data on the page.SummaryDifference0.0%

- Check90 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, indicating recruitment has ceased. A new Revision: v3.6.0 entry has been added, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.